An 80-year-old gentleman was admitted with a one-week history of myalgia and inability to walk. Investigations revealed an elevated AST (2069U/l), myoglobinuria (see Appendix Figure 1 on the website) and high creatine kinase (87564U/l). He subsequently developed renal failure requiring haemofiltration. His drug history showed a 4-week course of erythromycin whilst concurrently taking simvastatin. This interaction caused delayed onset of rhabdomyolysis from which he made a full recovery.
Informed Consent
The patient has signed a written consent form for publication of this case report.
Supplementary data
Supplementary data for this article is available online at http://ageing.oxfordjournals.org. Examination revealed signs of a dorsal column sensory neuropathy.
Appropriate investigation revealed no other cause for dorsal column sensory loss.
Symptoms and signs improved completely on cessation of the supplement after a period of weeks.
Dorsal column toxicity due to pyridoxine has been described since the 1980s [1] [2] [3] . In the series (n = 24, age range 20-53 years), the daily dose of B6 varied from 200 mg to 6 g. Only one serum level was reported as 'in excess of 30 ng/ml' (120 nmol/l) [1] which accords with the level (171 nmol/l) demonstrated in this case. A recent case report from the Netherlands suggested a toxic effect of B6 at a daily dose of 24-40 mg in two men in their seventh decade [4] . A similar dose to that is described here.
A safe dose of 150-200 mg daily is suggested by the experience of one US centre [5] albeit in a younger cohort of 70 individuals. The US no-observed-adverse-effect level is set at 200 mg, safe upper limit at 100 mg and recommended daily amount (RDA) 2 mg [6] .
